Last reviewed · How we verify
Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study
This registry aims to monitor the safety of Xueshuantong Injection and to identify the potential risk factors for the adverse drug reactions.
Details
| Lead sponsor | Zhong Wang |
|---|---|
| Status | UNKNOWN |
| Enrolment | 30000 |
| Start date | 2019-02-18 |
| Completion | 2022-06 |
Conditions
- Adverse Drug Event
- Adverse Drug Reactions
- Anaphylactic Reaction
- Severe Adverse Reactions
Interventions
- Xueshuantong-Injection
Primary outcomes
- The incidence of severe adverse reactions (SAR) of Xueshuantong-Injection — 2 years
A serious adverse reactions (SAR) is any untoward medical occurrence suspected to be medicinal product-related that at any dose: Results in death, is life-threatening, NOTE: The term "life-threatening" in the definition of "serious" refers to an event in which the patient was at risk of death at the time of the event; it does not refer to an event which hypothetically might have caused death if it were more severe. Requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, or Is a congenital anomaly/birth defect.
Countries
China